Kenneth L. van Golen Department of Biological Sciences, The Center for Translational Cancer Research University of Delaware Biography Publications Institution JoVE Articles Kenneth L. van Golen has not added a biography. If you are Kenneth L. van Golen and would like to personalize this page please email our Author Liaison for assistance. Publications Breast Cancer Stem Cells Survive Periods of Farnesyl-transferase Inhibitor-induced Dormancy by Undergoing Autophagy Bone Marrow Research. 2011 | Pubmed ID: 22046561 Individual Rac GTPases Mediate Aspects of Prostate Cancer Cell and Bone Marrow Endothelial Cell Interactions Journal of Signal Transduction. 2011 | Pubmed ID: 21776386 Farnesyl Transferase Inhibitor Treatment of Breast Cancer Cells Leads to Altered RhoA and RhoC GTPase Activity and Induces a Dormant Phenotype International Journal of Cancer. Journal International Du Cancer. Jul, 2011 | Pubmed ID: 20824700 Angiogenesis, Lymphangiogenesis, Growth Pattern, and Tumor Emboli in Inflammatory Breast Cancer: a Review of the Current Knowledge Cancer. Jun, 2010 | Pubmed ID: 20503405 Type I Collagen Receptor (alpha2beta1) Signaling Promotes Prostate Cancer Invasion Through RhoC GTPase Neoplasia (New York, N.Y.). Aug, 2008 | Pubmed ID: 18670640 CCL2 Induces Prostate Cancer Transendothelial Cell Migration Via Activation of the Small GTPase Rac Journal of Cellular Biochemistry. Aug, 2008 | Pubmed ID: 18646053 Novel Surface Expression of Reticulocalbin 1 on Bone Endothelial Cells and Human Prostate Cancer Cells is Regulated by TNF-alpha Journal of Cellular Biochemistry. Aug, 2008 | Pubmed ID: 18561328 Rho GTPases in PC-3 Prostate Cancer Cell Morphology, Invasion and Tumor Cell Diapedesis Clinical & Experimental Metastasis. 2008 | Pubmed ID: 18461284 Stepping out of the Flow: Capillary Extravasation in Cancer Metastasis Clinical & Experimental Metastasis. 2008 | Pubmed ID: 17906932 Is Caveolin-1 a Viable Therapeutic Target to Reduce Cancer Metastasis? Expert Opinion on Therapeutic Targets. Oct, 2006 | Pubmed ID: 16981828 Type I Collagen Receptor (alpha 2 Beta 1) Signaling Promotes the Growth of Human Prostate Cancer Cells Within the Bone Cancer Research. Sep, 2006 | Pubmed ID: 16951179 Insulin-like Growth Factor-I Receptor Expression Regulates Neuroblastoma Metastasis to Bone Cancer Research. Jul, 2006 | Pubmed ID: 16818629 Identification of Cell-of-origin Breast Tumor Subtypes in Inflammatory Breast Cancer by Gene Expression Profiling Breast Cancer Research and Treatment. Feb, 2006 | Pubmed ID: 16261404 Overexpression of Caveolin-1 and -2 in Cell Lines and in Human Samples of Inflammatory Breast Cancer Breast Cancer Research and Treatment. Feb, 2006 | Pubmed ID: 16244790 The Current Understanding of the Molecular Determinants of Inflammatory Breast Cancer Metastasis Clinical & Experimental Metastasis. 2005 | Pubmed ID: 16642401 Multiple Signaling Pathways Are Activated During Insulin-like Growth Factor-I (IGF-I) Stimulated Breast Cancer Cell Migration Breast Cancer Research and Treatment. Sep, 2005 | Pubmed ID: 16187236 RhoC-GTPase is a Novel Tissue Biomarker Associated with Biologically Aggressive Carcinomas of the Breast Breast Cancer Research and Treatment. Sep, 2005 | Pubmed ID: 16187229 Regulation of Pancreatic Cancer Cell Migration and Invasion by RhoC GTPase and Caveolin-1 Molecular Cancer. 2005 | Pubmed ID: 15969750 Integrin Expression Regulates Neuroblastoma Attachment and Migration Neoplasia (New York, N.Y.). Jul-Aug, 2004 | Pubmed ID: 15256055 Rho-regulatory Proteins in Breast Cancer Cell Motility and Invasion Breast Cancer Research and Treatment. Mar, 2004 | Pubmed ID: 14999154 Inflammatory Breast Cancer: Relationship Between Growth Factor Signaling and Motility in Aggressive Cancers Breast Cancer Research : BCR. 2003 | Pubmed ID: 12793901 Reversion of RhoC GTPase-induced Inflammatory Breast Cancer Phenotype by Treatment with a Farnesyl Transferase Inhibitor Molecular Cancer Therapeutics. Jun, 2002 | Pubmed ID: 12479217 Copper Deficiency Induced by Tetrathiomolybdate Suppresses Tumor Growth and Angiogenesis Cancer Research. Sep, 2002 | Pubmed ID: 12208730 Suppression of Tumor Recurrence and Metastasis by a Combination of the PHSCN Sequence and the Antiangiogenic Compound Tetrathiomolybdate in Prostate Carcinoma Neoplasia (New York, N.Y.). Sep-Oct, 2002 | Pubmed ID: 12192595 Detection of Epstein-Barr Virus in Rapidly Growing Fibroadenomas of the Breast in Immunosuppressed Hosts Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc. Jul, 2002 | Pubmed ID: 12118114 Mitogen Activated Protein Kinase Pathway is Involved in RhoC GTPase Induced Motility, Invasion and Angiogenesis in Inflammatory Breast Cancer Clinical & Experimental Metastasis. 2002 | Pubmed ID: 12090470 N-Myc and Bcl-2 Coexpression Induces MMP-2 Secretion and Activation in Human Neuroblastoma Cells Oncogene. Jul, 2002 | Pubmed ID: 12085233 WISP3 is a Novel Tumor Suppressor Gene of Inflammatory Breast Cancer Oncogene. May, 2002 | Pubmed ID: 12082632 Characterization of RhoC Expression in Benign and Malignant Breast Disease: a Potential New Marker for Small Breast Carcinomas with Metastatic Ability The American Journal of Pathology. Feb, 2002 | Pubmed ID: 11839578 RhoC GTPase Activation Assay Michelle Lucey1, Heather Unger1, Kenneth L. van Golen1 1Department of Biological Sciences, The Center for Translational Cancer Research, University of Delaware JoVE 2083 Biologie
RhoC GTPase Activation Assay Michelle Lucey1, Heather Unger1, Kenneth L. van Golen1 1Department of Biological Sciences, The Center for Translational Cancer Research, University of Delaware JoVE 2083 Biologie